Interestingly, Markiewicz and colleagues, with a negative enrichment approach based only on anti-CD45 magnetic beads, found that an EMT subtype of CTCs did not have any significant impact on the survival of early BC patients [32]. The gene discussed is PTPRC; the disease is breast cancer.